Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

Citations Over TimeTop 10% of 2014 papers

Abstract

The multi-strain probiotic was associated with a statistically significant improvement in overall symptom severity in patients with IBS, and was well tolerated. These results suggest this probiotic confers benefit in IBS and deserves further investigation (ISRCTN identifier: 77512412).

Related Papers

• → Stability of irritable bowel syndrome using a Rome II‐based classification(2005)39 cited
• → Prevalence of Irritable Bowel Syndrome in Chronic Fatigue(1996)57 cited
• Irritable Bowel Syndrome and Relationship Between Emotional Factors Probe(2011)
• → Irritable Bowel Syndrome(2008)8 cited
• → Μελέτη της πολυπαραγοντικής αναλγησίας στο μετεγχειρητικό πόνο μετά από λαπαροσκοπική χολοκυστεκτομή(2014)